With Echoes Of Theranos, Truvian Sciences Revives The Dream Of Low-cost, Accessible Blood Tests

A little over a year after the dissolution of the once high-flying blood testing startup Theranos, another startup has raised more than $27 million to breathe new life into the vision of bringing low-cost blood tests to point-of-care medical facilities